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Sox2 is a key transcription factor required for the maintenance of pluripotency in embryonic cells and
morphogenesis of several epithelia. In this issue of Cell Stem Cell, Arnold et al. (2011) demonstrate that
Sox2 marks long-lived adult stem cells to ensure homeostasis in a broad range of adult tissues.Sox2 is amember of the SRY-related High
Mobility Group transcription factor family
expressed in pluripotent embryonic stem
cells (ESCs). Sox2 is part of the core
of the pluripotency network that acts
together with other transcription factors,
such asOct4 or Nanog, to promote plurip-
otency (Jaenisch and Young, 2008). The
essential role of Sox2 during early embry-
onic development has been demon-
strated by the failure of Sox2 null embryos
to develop further than the epiblast stage
(Avilion et al., 2003). The role of Sox2 in
controlling the pluripotent state is also
demonstrated by the higher efficiency of
induced reprogramming to pluripotency
of somatic cells when Sox2 is coex-
pressed with Oct4, Klf4, and c-Myc in a
cocktail of reprogramming factors (Jae-
nisch and Young, 2008).
Sox2 is expressed at later stages
of embryonic development in different
tissues and organs (Figure 1B). Using
Sox2-GFP knockin mice, Ellis and col-
leagues investigated the pattern of Sox2
expression in the developing embryo and
adult mice. They found that Sox2 is
expressed in the neural tube and within
the proliferating neuronal progenitors
during embryonic development and in
adult mice (Ellis et al., 2004). Changing
the dose of Sox2 during development re-
sulted in major defects of neurogenesis,
highlighting the role of Sox2 in prevent-
ing neuronal progenitor differentiation
(Graham et al., 2003). Sox2 is expressed
in the foregut endoderm, in particular
in the prospective esophagus and ante-
rior stomach. Hypomorphic Sox2 muta-
tions in mice recapitulate the patho-
logical conditions associated with the
disorder caused by Sox2 mutations in
humans, called anophthalmia-esopha-
geal-genital syndrome, with symptoms
including mircrophthalmia (small eyes)and tracheo-esophageal fistula (commu-
nication between the trachea and the
esophagus) (Que et al., 2007). In the
absence of Sox2, cells of the anterior
stomach ectopically express genes of the
glandular stomach and intestine, suggest-
ing that Sox2 may establish the boundary
between the anterior and the glandular
stomach (Que et al., 2007). Absence of
Sox2 also results in the abnormal differen-
tiation of tracheal cells and lung epithelial
cells, and postnatal expression of Sox2 is
required to sustain the homeostasis of
the trachea and the ability of tracheal cells
to regenerate the epithelium upon injury
(Que et al., 2009). All together, these data
indicate that Sox2 is expressed at differ-
ent stages of embryonic development and
persists in certain adult tissues. However,
no systematic analysis of the full pattern
of Sox2 expression in adult tissues has
been performed and, more importantly,
the identity and function of Sox2-express-
ing cells in adult tissues remain unclear.
To elucidate the functional role of Sox2
in adult tissue, Arnold and colleagues first
performed a systematic survey of Sox2
expression in adult tissues using Sox2-
GFP knockin mice and Sox2 immuno-
staining. They confirmed the previously
reported expression of Sox2 in neuro-
genic zones of the brain, retina, tongue,
trachea, and bronchiolar epithelium. In
addition, they also identified, for the first
time, Sox2 expression in testis, cervix,
lens epithelium, glandular stomach, and
squamous epithelia of the esophagus
(Figure 1).
The broad range of Sox2 expression in
these renewing tissues prompted the
authors to determine more precisely the
contribution of Sox2-expressing cells to
tissue homeostasis. To this end, they
generated novel genetically engineered
mice, harboring a tamoxifen (TAM)-induc-Cell Stem Cellible Cre allele (CreER) or a suicide gene
(Herpes Simplex Thymidine Kinase, or
HSTK) in the Sox2 locus, in order to per-
form temporally regulated lineage tracing
and fate mapping analysis of Sox2-
expressing cells, as well as lineage abla-
tion of Sox2+ cells following drug adminis-
tration. TAM administration to adult
Sox2-CreER/ROSA26-lsl-EYFP mice re-
sulted in the initial labeling of cells within
the testis, pylorus and corpus of the
glandular stomach, and the basal layer
of the lens, as well as in other tissues in
which Sox2 was previously shown to be
expressed, including the tongue, esoph-
agus, forestomach, cervix, and anus
(Figure 1C). Several months after TAM
administration, all these tissues were still
strongly YFP+. The long-term persistence
and expansion of Sox2-derived cells in
these lineage-tracing experiments are
consistent with the targeting of long-lived
stem cells within these tissues. Sox2+
adult stem cells can be either unipotent
(e.g., germ and lens stem cells) or multi-
potent at the population level, such as
those in the stomach, where Sox2+ stem
cells differentiate into parietal, neuroen-
docrine, and glandular mucin-producing
cells of the glandular stomach. Lineage
tracing experiments recently showed
that Lgr5 is also expressed by stem cells
of the adult stomach (Barker et al.,
2010). However, Sox2 and Lgr5 seem to
mark two separate populations of cells.
Further studies will be needed to deter-
mine whether Sox2+ and Lgr5+ stem cells
are hierarchically connected or represent
purely independent classes of stomach
stem cells. Furthermore, it is unclear
whether all Sox2+ cells are equipotent
adult stem cells that balance self-renewal
and differentiation in a stochastic manner,
or alternatively,whether only a subpopula-
tion of Sox2+ cells are bona fide stem9, October 7, 2011 ª2011 Elsevier Inc. 283
Figure 1. Sox2 Expression in Pluripotent Cells, Embryonic Progenitors, and Adult StemCells
Sox2 is expressed in the inner cell mass of the blastocyst (A) and in the developing embryo. At E15.5, Sox2
is expressed in the foregut endoderm derivatives, as well as in neuronal, inner ear, retina, and lens progen-
itors (B). In adult mice, Sox2 is expressed in tissue stem cells of stratified and glandular epithelia of ecto-
dermal and endodermal origin, including the glandular stomach, the esophagus, the tongue, the brain, the
trachea, and the bronchiolar epithelium, as well as in sensory cells (Merkel and taste bud cells) and sper-
matogonial stem cells (C).
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Previewscells. It has been proposed that adult
Sox2+ neuronal stem cells derive from
embryonic Sox2+ progenitors (Suh et al.,
2007). TAM administration to Sox2-
CreER/ROSA26-lsl-EYFP pregnant mice
between E13.5 and E15.5 induced YFP
expression in the prospective adult
tissues expressing Sox2 (Arnold et al.,
2011), consistent with the notion that
adult Sox2+ stem cells arise from embry-
onic Sox2+ progenitors.
To further underscore the long-term
renewal potential of Sox2+ stem cells,
the authors isolated spermatogonia
based on Sox2-GFP and c-kit expression
and transplanted different cell popu-
lations (Sox2-GFP+/c-kit, Sox2-GFP+
c-kit+, and Sox2-GFP) into the testes of
infertile male mice. They showed that
only Sox2-GFP+/c-kit cells contain sper-
matogonial stem cells, because only
these cells, but not Sox2-GFP or Sox2+/
c-kit+ cell populations, could restore fer-
tility by repopulating seminiferous tubules
and differentiated mature sperm (Arnold
et al., 2011).284 Cell Stem Cell 9, October 7, 2011 ª2011Finally, to further substantiate the func-
tion of Sox2-expressing cells in maintain-
ing homeostasis of different adult tissues,
the authors performed lineage ablation of
Sox2+ cells by administrating ganciclovir
(GCV) to adult Sox2-HSTK knockin mice.
GCV is transformed into a toxic metabo-
lite that kills cells expressing HSTK. As
expected, GCV administration resulted
in massive apoptosis in Sox2-expressing
cells, inducing major defects of tissue
homeostasis that lead to the death of
the mice after 2 weeks of treatment.
When the treatment was withdrawn after
1 week, the pathological phenotype
reverted to normal, concomitant with
the replenishment of Sox2+ progenitors
in these tissues (Arnold et al., 2011).
This remarkable study demonstrates
that Sox2 is expressed in, and regulates
the function of many types of, adult
stem cells. The conserved role of Sox2
in regulating the function of a broad
range of stem cells, including pluripotent
stem cells, various tissue-specific embry-
onic progenitors, and adult stem cells,Elsevier Inc.suggests that Sox2may act as a common
‘‘stemness’’ gene regulating the self-
renewal potential of many different
classes of stem cells. It will be important
to define whether Sox2 functions in these
various stem cells by regulating common
or different sets of genes. It will also be
important to determine whether the
amplification of Sox2 found in esophageal
and lung squamous cell carcinoma (Bass
et al., 2009) promotes self-renewal and
stemness of tumor cells and whether
Sox2-expressing cancer cells represent
the so-called cancer stem cells of these
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